Pichaya Thanindratarn

5PUBLICATIONS
3CO-AUTHORS
Medical and biological physics not elsewhere classifiedMolecular targetsPredictive and prognostic markersSolid tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Aug 13, 2026
osteopoikilosis and fracture healing: the bone quantity-quality paradox-a case report and systematic review with synthesis without meta-analysis.

|Jun 11, 2021
T-LAK cell-originated protein kinase (TOPK): an emerging prognostic biomarker and therapeutic target in osteosarcoma.

Pichaya Thanindratarn, Ran Wei, Dylan C Dean

|Sep 22, 2020
T-LAK cell-originated protein kinase (TOPK) is a Novel Prognostic and Therapeutic Target in Chordoma.

Pichaya Thanindratarn, Dylan C Dean, Scott D Nelson

|Mar 13, 2020
Cyclin E1 is a prognostic biomarker and potential therapeutic target in osteosarcoma.

Ran Wei, Pichaya Thanindratarn, Dylan C Dean

|Nov 19, 2019
Establishment and Characterization of a Recurrent Osteosarcoma Cell Line: OSA 1777.

Pichaya Thanindratarn, Xiaoyang Li, Dylan C Dean

Pageof 1

Frequent Collaborators

4 joint publications

Zhenfeng Duan

1 joint publications

Rathapoom Suwanaratana

1 joint publications

Nuttawut Chanalithichai